Current status of immunotherapy for the treatment of lung cancer. - Wikidata - wikimedia - TriplyDB

Current status of immunotherapy for the treatment of lung cancer.

Current status of immunotherapy for the treatment of lung cancer.

http://www.wikidata.org/entity/Q35667739

about

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis Alveolar type II cells possess the capability of initiating lung tumor development The role of natural killer cells in pulmonary immunosurveillance.Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.Actual status of therapeutic vaccination in non-small cell lung cancer The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer.New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment

P2860

Q26769728-7DE6836E-042F-4D82-A2A1-6111D7F160DA Q33636990-89803D88-9F49-4CFD-9092-2B2BAB765461 Q34241776-0E56D73C-1C51-4188-AD5D-A01AAC0CB6F7 Q34535276-8487686E-2557-44A1-8BF6-22DD27282097 Q35549712-C0B93350-76DC-43CC-B9A2-774FCBE39722 Q37542216-D6D85EC6-32F5-4E96-97D9-3F1DBA592AD8 Q38223388-6CCEA1D8-0066-4A1F-911D-EE240892DE32 Q42911493-94AE2AB7-482B-41B7-81F7-96B68EFD3CC5 Q58783978-C3867A27-01F8-4D8C-A221-D663A573DA4C

P2860

Current status of immunotherapy for the treatment of lung cancer.

http://www.wikidata.org/entity/Q35667739

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Current status of immunotherapy for the treatment of lung cancer.

@ast

Current status of immunotherapy for the treatment of lung cancer.

@en

type

label

Current status of immunotherapy for the treatment of lung cancer.

@ast

Current status of immunotherapy for the treatment of lung cancer.

@en

prefLabel

Current status of immunotherapy for the treatment of lung cancer.

@ast

Current status of immunotherapy for the treatment of lung cancer.

@en

P1433

Q35667739-3A625A12-1EE9-43A1-83EC-60AB63C43B5F

P1476

Q35667739-BDF1CB59-2215-4246-B9E8-252AAACFDA45

P2093

Q35667739-0878C1DF-1B69-4565-B83A-432A06537842

Q35667739-4AFBE835-9A3C-4882-BDD3-36BDF5C50A6A

Q35667739-64EC255F-D9FB-4B49-8610-1B00E19F6B2E

Q35667739-904E38E3-4D37-4F18-8249-328DD93CE63F

P2860

Q35667739-01E68462-5D51-470A-BBDF-BABEA1B37D4F

Q35667739-070EF648-37EB-4858-950B-86C3586CBFC1

Q35667739-07F8F9C4-5591-4322-9268-24CCF66996E8

Q35667739-0906F318-3B9B-4A8F-9175-30C1CA25656F

Q35667739-0AD81FFC-2B48-4CE4-A78F-EB82B7FD443E

Q35667739-0B730C2D-BC7D-4579-ABD0-A406BCAC09A4

Q35667739-0BD0D3E9-5F24-442B-883D-6F4EBB427F04

Q35667739-13647C71-0D5A-4CD4-8BEF-9CB04DF20F4E

Q35667739-13E4CD2E-17B0-4B7D-A762-DA88387A7231

Q35667739-1947BA87-91FA-48C5-8417-40E5E770DD48

P304

Q35667739-09F08CC0-B141-4CE0-873B-70F95B434F26

P31

Q35667739-50184885-B10D-4511-9917-809045080E7B

P356

Q35667739-A66E84CB-991F-4FB0-BC9A-5E004B594898

P433

Q35667739-117F5945-D481-4295-B933-658C576E1844

P478

Q35667739-2A2BD28C-EC75-4FE2-B6CF-77585AD3AE30

P50

Q35667739-D6FE47EC-018B-42FF-9AD3-FE06E30A760D

P577

Q35667739-A218B8E7-22D7-48F7-93B2-9890F4FB1903

P5875

Q35667739-D21307A5-ACDF-4C68-94CC-5F3429769AB5

P698

Q35667739-2007DC13-7119-49CD-A435-183269BC11B1

P921

Q35667739-BD737563-9D8F-4F53-8D8F-7E4E7287201E

P932

Q35667739-970F926B-2886-4EC9-A09F-D1266BE44108

P356

J.ISSN.2072-1439.2010.11.6

P1433

Journal of thoracic disease

P1476

Current status of immunotherapy for the treatment of lung cancer

@en

P2093

Alexander S Krupnick

http://www.w3.org/2001/XMLSchema#string

Andrew E Gelman

http://www.w3.org/2001/XMLSchema#string

Daniel Kreisel

http://www.w3.org/2001/XMLSchema#string

Sanjay Murala

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin

An endotoxin-induced serum factor that causes necrosis of tumors

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Cancer regression in patients after transfer of genetically engineered lymphocytes

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Cancer statistics, 2010

The consensus coding sequences of human breast and colorectal cancers

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Myeloid-derived suppressor cells as regulators of the immune system

P304

237-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2072-1439.2010.11.6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221764557

http://www.w3.org/2001/XMLSchema#string

P698

22263052

http://www.w3.org/2001/XMLSchema#string

P921

P932

3256475

http://www.w3.org/2001/XMLSchema#string